The ReadoutModerna says its vaccine is variant-proof, J&J’s data looms, & Regeneron’s biggest drug faces competition By Damian Garde Jan. 26, 2021 Reprints Alex Hogan/STAT The Readout for January 26, 2021 About the Author Reprints Damian Garde National Biotech Reporter Damian Garde covers biotech, is a co-writer of The Readout newsletter, and a co-host of "The Readout LOUD" podcast. [email protected] @damiangarde
The Readout Meghana Keshavan Regeneron targets obesity, a new microbiome deal, & comparing cancer drug costs
The Readout Damian Garde Should the feds investigate Aduhelm? Plus: biotech’s biggest binaries & regenerating heart tissue
Exclusive Rachel Cohrs STAT Plus: With Fat Joe concerts and Super Bowl ads, a cadre of billionaires is mounting an unorthodox campaign against hospitals
Matt's Take Matthew Herper STAT Plus: Battle for the soul of Illumina is also a referendum on its CEO
Health Tech Casey Ross, Brittany Trang and Mario Aguilar STAT Plus: What does generative AI mean for health care? We asked the experts